Carl Zeiss Meditec AG (CZMWY)
35.14
+0.14
(+0.41%)
USD |
OTCM |
Oct 02, 16:00
Carl Zeiss Meditec Cash from Operations (TTM) : 347.93M for March 31, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 347.93M |
| September 30, 2025 | 241.52M |
| March 31, 2025 | 212.92M |
| September 30, 2024 | 268.96M |
| March 31, 2024 | 288.03M |
| September 30, 2023 | 272.96M |
| March 31, 2023 | 160.28M |
| September 30, 2022 | 194.64M |
| March 31, 2022 | 333.40M |
| Date | Value |
|---|---|
| September 30, 2021 | 432.23M |
| March 31, 2021 | 340.66M |
| September 30, 2020 | 202.45M |
| March 31, 2020 | 188.97M |
| September 30, 2019 | 245.47M |
| March 31, 2019 | 280.47M |
| September 30, 2018 | 220.31M |
| March 31, 2018 | 66.55M |
| September 30, 2017 | 42.91M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| IDEXX Laboratories, Inc. | 1.368B |
| Neogen Corp. | 83.20M |
| QuidelOrtho Corp. | -57.20M |
| Smith & Nephew plc | 1.330B |
| Trinity Biotech Plc | -- |